Specialty Pharmacy

HIV prevention and treatment recommendations for adults can be found with new AIDSinfo app.

Abbott's Compounding Pharmacy is voluntarily recalling all of its unexpired lots of sterile compounded products, including injectable medications, eye drops, sterile solutions, and eye ointments, out of concern for sterility assurance.

One-third of HIV-infected Americans are co-infected with hepatitis C virus (HCV), and 75% to 90% of HIV-positive intravenous drug users are co-infected.

A pharmacist facing sentencing in March for defrauding Medicaid has been found dead in his house.

Researchers examine how genetic changes in breast cancer cells interfere with pathways critical to disease growth and survival.

Study seeks to address underpayments received by low-income Medicare beneficiaries or dual eligibles.

Research examines accuracy of health care information on discussion board web sites Reddit, Mumsnet, and Patient.

Fingolimid is an oral treatment for relapsing-remitting multiple sclerosis.

Researchers call for regular HIV testing and pre-exposure prophylaxis combined with early treatment.

Arzerra found to nearly double progression-free survival in chronic lymphocytic leukemia compared with observation.

Metformin decreased inflammation and scarring observed in more common pancreatic cancers.

Heather Bonome, PharmD, director of Pharmacy Segment at URAC, discusses what comprises an effective pharmacy accreditation program.

Combination of diclofenac with chemotherapy and radiation may greatly improve treatment of cancer patients.

Pomalyst was approved in 2013 for use in combination with dexamethasone to inhibit tumor growth.

Health care coverage among parents has increased, but many remain unable to afford coverage.

Cheese contains a natural food preservative, nisin, which can destroy cancer cells.

BioMarin Pharmaceutical Inc's new drug application for drisapersen as a treatment for Duchenne muscular dystrophy has been rejected by the FDA.

Unexplained drug cost increases are the epicenter of some of the most polemic conversations in US health policy today.

Cosentyx was previously approved for the treatment of moderate-to-severe plaque psoriasis.

Controversial proposal would essentially replace health care plans Americans currently obtain via their employers or purchased individually.

Few state minor-consent laws authorize participation in clinical trials and therapies.

Pricing Sovaldi based on the predicted benefits of therapy in specific hepatitis C patient groups could ultimately lead to greater access for patients.

Large geographic disparities exist in the likelihood of either being removed from the transplant list due to progressive disease or actually receiving a transplant.

Process attaches disease-related protein fragments to spleen cells to prevent MS.

Predictors of higher cost include older age, male sex, and hospital location.

Patients with type 2 diabetes have about a 60% greater risk for developing dementia than their non-diabetic counterparts.

Whether transient, spontaneous, or a triggered exacerbation of adequately controlled baseline aches, breakthrough pain is a difficult symptom for providers to gauge.

Research examines long non-coding RNAs as biomarkers and therapeutic targets.

Top news of the week in cancer drug development and research.

PKN proteins are gaining recognition as drug targets for cancer research.